Administration of a Bifidobacterium cocktail (B. bifidum, B. longum, B. lactis, and B. breve) or STING agonist DMXAA synergized the anti-tumor efficacy of CD47 blockade in mice non-responders in a STING-dependent way. Here, CD47 is linked to neoplasm.